Triochem Product

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE331E01013
  • NSEID:
  • BSEID: 512101
INR
17.40
0.00 (0.00%)
BSENSE

Nov 20

BSE+NSE Vol: 0

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

0

Shareholding (Sep 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

68.65%

When is the next results date for Triochem Product?

16-May-2025

No Upcoming Board Meetings

Who are in the management team of Triochem Product?

16-Jul-2025

As of March 2023, the management team of Triochem Product includes Ramu S Deora (CEO), Sunil S Jhunjhunwala (Independent Director), S S Sharma (Director), Girish Kumar Pungalia (Independent Director), Rajesh Ramu Deora (Director), Ureca Shirish Shirole (Company Secretary), and Grace R. Deora (Non-Executive Director). Each member contributes to the company's governance and operations.

As of March 2023, the management team of Triochem Product includes the following individuals:<BR><BR>1. Ramu S Deora - Director & Chief Executive Officer<BR>2. Sunil S Jhunjhunwala - Independent Director<BR>3. S S Sharma - Director<BR>4. Girish Kumar Pungalia - Independent Director<BR>5. Rajesh Ramu Deora - Director<BR>6. Ureca Shirish Shirole - Company Secretary & Compliance Officer<BR>7. Grace R. Deora - Non-Executive Director<BR><BR>Each member plays a significant role in the governance and operational oversight of the company.

Read More

What does Triochem Product do?

17-Jul-2025

Triochem Products Ltd manufactures and exports pharmaceutical products, APIs, and chemicals, operating as a Micro Cap company. As of March 2025, it reported a net profit of -4 Cr.

Overview:<BR>Triochem Products Ltd is engaged in the manufacturing and exporting of pharmaceutical products, APIs, and chemicals, operating within the Pharmaceuticals & Biotechnology industry and classified as a Micro Cap company.<BR><BR>History:<BR>The company was incorporated on January 17, 1972. The latest quarterly results reported are for March 2025, during which the company recorded a net profit.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: -4 Cr (Quarterly Results - Mar 2025)<BR>Market-cap value: INR Cr (Micro Cap)<BR><BR>Key Metrics:<BR>Industry P/E: N/A<BR>Dividend Yield: 0.00%<BR>Debt Equity: 0.00<BR>Return on Equity: 0.00%<BR>Price to Book: 0.00<BR><BR>Contact Details:<BR>Address: Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001<BR>Phone: 91-22-22663150<BR>Email: investor@triochemproducts.com<BR>Website: http://www.triochemproducts.com

Read More

Who are the top shareholders of the Triochem Product?

17-Jul-2025

The top shareholders of Triochem Product include Rajesh Ramu Deora with 14.69%, Ambernath Plasto Packaging Private Limited at 4.9%, and individual investors holding a combined 15.53%. There are no mutual funds or foreign institutional investors currently involved.

The top shareholders of Triochem Product include the promoters, with Rajesh Ramu Deora holding the largest share at 14.69%. Additionally, Ambernath Plasto Packaging Private Limited is the highest public shareholder, owning 4.9%. Individual investors collectively hold 15.53% of the shares. There are currently no mutual funds or foreign institutional investors holding shares in the company.

Read More

Why is Triochem Product falling/rising?

19-Nov-2025

As of 19-Nov, Triochem Products Ltd is priced at 17.40 with no change in its stock price, significantly underperforming against its sector and the benchmark Sensex. The stock has shown erratic trading behavior and has not traded on 5 of the last 20 days, indicating weak performance relative to the market.

As of 19-Nov, Triochem Products Ltd is currently priced at 17.40, showing no change (0.00%) in its stock price. The stock has underperformed significantly today, with a performance that is down by 99.34% compared to its sector. Additionally, the stock has not traded on 5 out of the last 20 days, indicating erratic trading behavior. It is also trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, month, and year-to-date, the stock has shown no change in its price, while the benchmark Sensex has increased by 0.85%, 1.47%, and 9.02%, respectively. Unfortunately, there is no information available regarding positive or negative factors impacting the stock.<BR><BR>In the broader market context, Triochem Products Ltd has not kept pace with the Sensex, which has outperformed the stock across various time frames. The stock's lack of movement contrasts sharply with the benchmark's gains, indicating a weak performance relative to the market. The BSE Small Cap index has gained by 1.42%, further highlighting the underperformance of Triochem Products Ltd in comparison to both its sector and the broader market.

Read More

Which are the latest news on Triochem Product?

20-Nov-2025
No latest news for Triochem Product found.

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR Cr (Micro Cap)

stock-summary
P/E

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2026)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Icon
Company does not have enough history
Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Announcement under Regulation 30 (LODR)-Newspaper Publication

05-Nov-2026 | Source : BSE

Unaudited Financial Results for the quarter and half year ended 30th September 2026 publice on Navshakti and Fee Press Journal on 5th November 2026 which is prroved by the Board in Its meeting on 4th November 2026

Submission Of Unaudited Standalone Financial Results For The Quarter And Half Year Ended 30Th September 2026

04-Nov-2026 | Source : BSE

The Board of Director of the Company at its meeting held today wednesday 4th November 2026 have inter-alia considered and approved the Unaudited Standalone Financial Results for the quarter and half year ened 30th September 2026 revired by the Audit Committee along with Statement of Assets and Liabilities as at 30th September 2026 and Cash Flow Statement for hte period ended 30th September 2026 along with Limited Review Report submitted by the Statutory Auditors of the Compnay

Submission Of Statement Of Deviation Or Variation In Public Issue Rights Issue Preferential Issue Etc. Under Regulation 32(1) Of The SEBI (Listing Obligation & Disclosures Requirement) Regulation 2015.

04-Nov-2026 | Source : BSE

Not Applicable as there is no offer made by way of publice issue right issue preferential issue etc

Corporate Actions stock-summary
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors
Quality key factors stock-summary

No Data Found

Valuation key factors

No Data Found

Technicals key factors
Indicator
Weekly
Monthly
Icon
Technical indicator has not been calculated since the stock has been active for a short period
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Rajesh Ramu Deora (14.69%)

Highest Public shareholder

Ambernath Plasto Packaging Private Limited (4.9%)

Individual Investors Holdings

15.53%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Sep'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Jun 2026",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2026 is -11.11% vs -98.92% in Jun 2026",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'26",
        "Jun'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.06",
          "val2": "-0.04",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.08",
          "val2": "0.09",
          "chgp": "-11.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.78",
          "val2": "-0.60",
          "chgp": "-30.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.22",
          "val2": "-0.12",
          "chgp": "-83.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.16",
          "val2": "-1.19",
          "chgp": "2.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.35",
          "val2": "-0.03",
          "chgp": "-1,066.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2026 is 2,092.50% vs 60.40% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.38",
          "val2": "-1.22",
          "chgp": "-13.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.08",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.17",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "7.97",
          "val2": "-0.40",
          "chgp": "2,092.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Sep'26 - QoQstock-summary
Sep'26
Jun'26
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.06
-0.04
-50.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
0.08
0.09
-11.11%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

QoQ Growth in quarter ended Sep 2026 is 0.00% vs 0.00% in Jun 2026

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Sep 2026 is -11.11% vs -98.92% in Jun 2026

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary
Sep'25
Sep'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-0.78
-0.60
-30.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.22
-0.12
-83.33%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

Growth in half year ended Sep 2025 is 0.00% vs 0.00% in Sep 2024

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -83.33% vs 89.38% in Sep 2024

Nine Monthly Results Snapshot (Standalone) - Dec'25stock-summary
Dec'25
Dec'24
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.16
-1.19
2.52%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.35
-0.03
-1,066.67%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in nine months ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is -1,066.67% vs 97.74% in Dec 2024

Annual Results Snapshot (Standalone) - Mar'26stock-summary
Mar'26
Mar'25
Change(%)
Net Sales
0.00
0.00
Operating Profit (PBDIT) excl Other Income
-1.38
-1.22
-13.11%
Interest
0.08
0.00
Exceptional Items
11.17
0.00
Standalone Net Profit
7.97
-0.40
2,092.50%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
Values in Rs Cr.
Net Sales

YoY Growth in year ended Mar 2026 is 0.00% vs 0.00% in Mar 2025

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2026 is 2,092.50% vs 60.40% in Mar 2025

stock-summaryCompany CV
About Triochem Products Ltd stock-summary
stock-summary
Triochem Products Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Triochem Products Ltd was incorporated in the year January 17, 1972. The Company is engaged in the business of manufacturer and exporter of pharmaceuticals products, API and chemicals.
Company Coordinates stock-summary
Company Details
Sambhava Chambers, 4th Floor Sir P M Road Mumbai Maharashtra : 400001
stock-summary
Tel: 91-22-22663150
stock-summary
investor@triochemproducts.com
Registrar Details
Sharex (India) Pvt Ltd , Unit No.1, Luthra Ind.Premises Andheri Kurla Road, Safed Pool , Mumbai